Endometrial Cancer Patients: A Cohort Previous to Changes in Tumour Behaviour and Treatment Strategies

<table>5-year disease-specific survival within FIGO stage I endometrioid adenocarcinoma <svg height="11.0375" id="M13" style="vertical-align:-0.17555pt" version="1.1" viewbox="0 0 50.724998 11.0375" width="50.724998" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.0375)">
<g transform="translate(72,-63.17)">
<text transform="matrix(1,0,0,-1,-71.95,63.4)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">1</tspan>
<tspan style="font-size: 12.50px; " x="27.969212" y="0">3</tspan>
<tspan style="font-size: 12.50px; " x="34.220711" y="0">6</tspan>
</text>
</g>
</g>
</svg>, divided by histologic tumour grade. Period of diagnosis 2002–2009.</table>

International Scholarly Research Notices

fig3

Figure 3

Figure 3: Endometrial Cancer Patients: A Cohort Previous to Changes in Tumour Behaviour and Treatment Strategies 